HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos Gomez-Roca Selected Research

imgatuzumab

2/2014Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma.
10/2011Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor, in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlos Gomez-Roca Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 08/2009
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 09/2009
4Fatigue
01/2022 - 04/2016
3Exanthema (Rash)
01/2022 - 12/2018
3Diarrhea
01/2021 - 12/2018
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 02/2014
3Asthenia
01/2021 - 12/2018
3Melanoma (Melanoma, Malignant)
01/2021 - 09/2017
3Edema (Dropsy)
01/2021 - 10/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2020
2Giant Cell Tumors (Giant Cell Tumor)
01/2021 - 06/2014
2Febrile Neutropenia
12/2020 - 12/2018
2Mesothelioma
11/2020 - 09/2009
2Glioblastoma (Glioblastoma Multiforme)
02/2019 - 10/2016
2Renal Cell Carcinoma (Grawitz Tumor)
11/2017 - 01/2017
2Neoplasm Metastasis (Metastasis)
10/2009 - 08/2009
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022
1Adenocarcinoma
01/2021
1Body Weight (Weight, Body)
01/2021
1Anemia
12/2020
1Necrosis
12/2020
1Squamous Cell Carcinoma of Head and Neck
12/2020
1Lung Neoplasms (Lung Cancer)
11/2020
1Capillary Leak Syndrome
11/2020
1Hypotension (Low Blood Pressure)
11/2020
1Sjogren's Syndrome (Sjogren Syndrome)
01/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Tumor Lysis Syndrome
12/2018
1Vomiting
12/2018
1Thrombocytopenia (Thrombopenia)
12/2018
1Paronychia
12/2018
1Stomatitis
12/2018
1Stomach Neoplasms (Stomach Cancer)
12/2018
1Breast Neoplasms (Breast Cancer)
12/2018
1Acute Coronary Syndrome
01/2018

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
01/2021 - 06/2012
5Immune Checkpoint InhibitorsIBA
01/2022 - 10/2017
4Monoclonal AntibodiesIBA
01/2022 - 10/2011
4emactuzumabIBA
01/2022 - 06/2014
4Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2009
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 09/2009
3CreatinineIBA
12/2020 - 10/2020
3pembrolizumabIBA
11/2020 - 01/2017
3EverolimusFDA Link
11/2017 - 10/2011
3Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 01/2014
2regorafenibIBA
01/2022 - 01/2021
2LigandsIBA
01/2022 - 12/2017
2avelumabIBA
01/2022 - 01/2021
2Biological ProductsIBA
01/2021 - 08/2009
2Macrophage Colony-Stimulating FactorIBA
01/2021 - 10/2020
2N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA
01/2021 - 01/2021
2Indicators and Reagents (Reagents)IBA
01/2021 - 01/2014
2Alanine Transaminase (SGPT)IBA
12/2020 - 01/2018
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2020 - 10/2020
2AfatinibIBA
12/2018 - 12/2018
2RG7356IBA
11/2016 - 05/2016
2OTX015IBA
04/2016 - 01/2016
2imgatuzumabIBA
02/2014 - 10/2011
2ErbB Receptors (EGF Receptor)IBA
10/2011 - 10/2009
1NivolumabIBA
01/2022
1Exonucleases (3' 5' Exonuclease)IBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1atezolizumabIBA
01/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1GTP Phosphohydrolases (GTPases)IBA
01/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2021
1CytokinesIBA
01/2021
1CrizotinibIBA
01/2021
1Proteoglycans (Proteoglycan)IBA
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1Lipase (Acid Lipase)FDA Link
12/2020
1Inhibitor of Apoptosis ProteinsIBA
12/2020
1MesothelinIBA
11/2020
1LMB-100IBA
11/2020
1Immunotoxins (Immunotoxin)IBA
11/2020
1Surface Antigens (Surface Antigen)IBA
11/2020
1EnzymesIBA
11/2020
1selicrelumabIBA
10/2020
1Topoisomerase II InhibitorsIBA
01/2019
1F14512IBA
01/2019
1plocabulinIBA
01/2019
1PlatinumIBA
01/2019
1PolyaminesIBA
01/2019
1GemcitabineFDA Link
12/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2018
1Trastuzumab (Herceptin)FDA Link
12/2018
1Docetaxel (Taxotere)FDA Link
12/2018
1Sorafenib (BAY 43-9006)FDA Link
01/2018
1IntegrinsIBA
01/2018
1eribulinFDA Link
01/2018

Therapy/Procedure

8Therapeutics
11/2020 - 09/2009
5Immunotherapy
01/2022 - 05/2014
4Chemoradiotherapy
01/2022 - 01/2018
3Radiotherapy
01/2021 - 10/2016
1Drug Tapering
01/2019
1Injections
01/2019